Latest Contracts News

Rua Bioscience has approved a $600,000 convertible note facility aimed at boosting inventory purchases to accelerate its UK market expansion following a major distribution deal.

Talius has secured a substantial $850,000 purchase order from New Zealand’s Hato Hone St John, adding 8,000 devices and boosting its recurring revenue by $55,000 annually.

Contact Energy (ASX:CEN) posted a 62% jump in FY26 net profit to NZD 423 million, driven by its Manawa acquisition and a near 98% renewable generation mix, while committing to net zero emissions by 2035.

EVE Health Group has progressed its Libbo pilot clinical study for erectile dysfunction with dosing set for Q4 2026 and achieved a major solubility breakthrough for apixaban, while appointing Ben Rohr as CEO to drive commercial growth.

Metcash Limited posted a steady FY26 performance, with group revenue rising to $19.6 billion and EBITDA up 1.9%, driven by growth in Food and digital channels despite challenges in Hardware.

Invictus Energy has locked in a revised drilling contract with Exalo Drilling for the Musuma-1 exploration well, confirming a November 2026 spud date at Zimbabwe's Cabora Bassa Project. Preparations including rig maintenance, well services procurement, and wellpad construction are advancing steadily.

Lycopodium has secured a A$93 million EPCM contract to expand Artemis Gold’s Blackwater Mine in Canada, boosting the mine’s throughput capacity to one of the largest in the country.

Connected Minerals (ASX:CML) is mobilising a ~6,000m reverse circulation and diamond drilling program at its Bailundo Carbonatite Project in Angola, aiming to define a maiden JORC Mineral Resource for niobium and rare earth elements.

RocketDNA Ltd has secured a $1 million contract extension from BHP Mitsubishi Alliance to continue its autonomous drone operations in the Bowen Basin until October 2026, reinforcing its position in mining tech.

AVITA Medical posted robust Q2 2026 results with 18% revenue growth, driven by RECELL and supported by Cohealyx and PermeaDerm, and now expects to reach cash flow breakeven by year-end.

Wellnex Life has agreed to sell its Pain Away brand to Mentholatum Australasia for up to A$21.3 million, aiming to wipe out debt and sharpen its strategic focus.

Tasmea has finalized its acquisition of JPS Group, integrating a specialist energy services provider and boosting its FY27 earnings guidance. The deal adds a skilled workforce, blue-chip clients, and tech-enabled isolation services to Tasmea’s Mechanical segment.